196170 — Alteogen Share Price
- KR₩17tn
- KR₩17tn
- KR₩97bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 854.75 | ||
PEG Ratio (f) | 10.83 | ||
EPS Growth (f) | 374.14% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 91.24 | ||
Price to Tang. Book | 203.59 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 186.66 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -4.88% | ||
Return on Equity | -0.73% | ||
Operating Margin | -10.66% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 29,229.18 | 42,425.84 | 38,745.94 | 28,806.34 | 96,522.93 | 74,700 | 196,900 | 47.76% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +249.63 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.
Directors
- Sun Jae Park CEO (60)
- Seung Ju Lee VPR (57)
- Gyeong Hun Jung MDR (59)
- Min Seok Lee MDR (57)
- Sang Wu Kang OTH (55)
- Gyu Wan Kim OTH (55)
- Sang Mi Lee OTH (53)
- Yong Hae Park OTH (66)
- Hye Sin Jung DRC (63)
- Yang Wu Kim DRC (51)
- Jong Yin Choi NID (56)
- Yin Yeong Goh NID (64)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- May 13th, 2008
- Public Since
- December 12th, 2014
- No. of Shareholders
- 57,152
- No. of Employees
- 46
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 53,124,820
- Address
- 62, DAEJEON, 34054
- Web
- http://www.alteogen.com/
- Phone
- +82 423848780
- Auditors
- Echon Accounting Corp.
Upcoming Events for 196170
Q4 2024 Alteogen Inc Earnings Release
Similar to 196170
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
Anterogen Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:40 UTC, shares in Alteogen are trading at KR₩319,000. This share price information is delayed by 15 minutes.
Shares in Alteogen last closed at KR₩319,000 and the price had moved by +410.38% over the past 365 days. In terms of relative price strength the Alteogen share price has outperformed the FTSE Developed Asia Pacific Index by +384.21% over the past year.
The overall consensus recommendation for Alteogen is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAlteogen does not currently pay a dividend.
Alteogen does not currently pay a dividend.
Alteogen does not currently pay a dividend.
To buy shares in Alteogen you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩319,000, shares in Alteogen had a market capitalisation of KR₩17tn.
Here are the trading details for Alteogen:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 196170
Based on an overall assessment of its quality, value and momentum Alteogen is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alteogen is KR₩65,000. That is 79.62% below the last closing price of KR₩319,000.
Analysts covering Alteogen currently have a consensus Earnings Per Share (EPS) forecast of KR₩135 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alteogen. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +55.91%.
As of the last closing price of KR₩319,000, shares in Alteogen were trading +68.78% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alteogen PE ratio based on its reported earnings over the past 12 months is 854.75. The shares last closed at KR₩319,000.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Alteogen's management team is headed by:
- Sun Jae Park - CEO
- Seung Ju Lee - VPR
- Gyeong Hun Jung - MDR
- Min Seok Lee - MDR
- Sang Wu Kang - OTH
- Gyu Wan Kim - OTH
- Sang Mi Lee - OTH
- Yong Hae Park - OTH
- Hye Sin Jung - DRC
- Yang Wu Kim - DRC
- Jong Yin Choi - NID
- Yin Yeong Goh - NID